BIO-TECHNE (TECH) Debt to Equity: 2014-2025
Historic Debt to Equity for BIO-TECHNE (TECH) over the last 12 years, with Sep 2025 value amounting to $0.15.
- BIO-TECHNE's Debt to Equity rose 8.79% to $0.15 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.15, marking a year-over-year increase of 8.79%. This contributed to the annual value of $0.18 for FY2025, which is 16.95% up from last year.
- Latest data reveals that BIO-TECHNE reported Debt to Equity of $0.15 as of Q3 2025, which was down 15.37% from $0.18 recorded in Q2 2025.
- In the past 5 years, BIO-TECHNE's Debt to Equity registered a high of $0.23 during Q4 2023, and its lowest value of $0.11 during Q4 2022.
- For the 3-year period, BIO-TECHNE's Debt to Equity averaged around $0.18, with its median value being $0.18 (2023).
- Per our database at Business Quant, BIO-TECHNE's Debt to Equity crashed by 57.20% in 2021 and then spiked by 107.97% in 2023.
- Over the past 5 years, BIO-TECHNE's Debt to Equity (Quarterly) stood at $0.17 in 2021, then slumped by 33.92% to $0.11 in 2022, then surged by 107.97% to $0.23 in 2023, then tumbled by 36.60% to $0.14 in 2024, then increased by 8.79% to $0.15 in 2025.
- Its Debt to Equity was $0.15 in Q3 2025, compared to $0.18 in Q2 2025 and $0.16 in Q1 2025.